Psychopathology and D1 Receptor Availability in Schizophrenia

被引：0
|
作者：
Eisenberg, Daniel [1 ]
Kohn, Philip [1 ]
Gregory, Michael [1 ]
Hamborg, Madeline [1 ]
Czarapata, Jasmin [1 ]
Berman, Karen [1 ]
机构：
[1] NIMH, Bethesda, MD 20892 USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2021年 / 46卷 / SUPPL 1期
关键词：
Schizophrenia (SCZ); D1 Dopamine Receptors; Psychosis;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P478
引用
收藏
页码：332 / 332
页数：1
相关论文
共 50 条
  • [1] THE D1 RECEPTOR AND COGNITION AND TRIAL OF A NOVEL D1 AGONIST IN THE SCHIZOPHRENIA SPECTRUM
    Siever, Larry J.
    Rosell, Daniel
    McClure, Margaret
    Strike, Katherine
    Barch, Deanna M.
    Harvey, Philip
    Girgis, Ragy
    Lieberman, Jeffrey
    Giakoumaki, Stella
    Bitsios, Panos
    Roussos, Panos
    Haroutunian, Vahram
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S5 - S6
  • [2] SCHIZOPHRENIA AND THE D1 RECEPTOR - FOCUS ON NEGATIVE SYMPTOMS
    LYNCH, MR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1992, 16 (06): : 797 - 832
  • [3] Dopamine D1 receptor gene polymorphism and schizophrenia in Japan
    Kojima, H
    Ohmori, O
    Shinkai, T
    Terao, T
    Suzuki, T
    Abe, H
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 88 (02): : 116 - 119
  • [4] GSK-3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia
    Wang, Jing-Ru
    Sun, Pei-Hua
    Ren, Zhao-Xiang
    Meltzer, Herbert Y.
    Zhen, Xue-Chu
    CNS NEUROSCIENCE & THERAPEUTICS, 2017, 23 (02) : 174 - 187
  • [5] Targeting the dopamine D1 receptor in schizophrenia:: insights for cognitive dysfunction
    Goldman-Rakic, PS
    Castner, SA
    Svensson, TH
    Siever, LJ
    Williams, GV
    PSYCHOPHARMACOLOGY, 2004, 174 (01) : 3 - 16
  • [6] Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
    Patricia S. Goldman-Rakic
    Stacy A. Castner
    Torgny H. Svensson
    Larry J. Siever
    Graham V. Williams
    Psychopharmacology, 2004, 174 : 3 - 16
  • [7] CLOPENTHIXOL TREATMENT OF SCHIZOPHRENIA INCREASES DOPAMINE D1 RECEPTOR DENSITY
    REYNOLDS, GP
    CZUDEK, C
    SCHIZOPHRENIA RESEARCH, 1992, 6 (02) : 137 - 137
  • [8] Prefrontal dopamine transmission in schizophrenia:: Is D1 receptor A relevant biomarker?
    Abi-Dargham, A
    Guo, N
    Narendran, R
    Hwang, D
    Ekelund, J
    Guillin, O
    Martinez, D
    Frankle, G
    Laruelle, M
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 : S13 - S13
  • [9] D1 receptor binding and agonist effects on cognitive function in the schizophrenia spectrum
    Siever, LJ
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 84S - 85S
  • [10] Effect of dopamine D1 receptor gene polymorphisms on antipsychotic response in schizophrenia
    Hwang, RW
    Masellis, M
    Ni, X
    Czobor, P
    Chakos, M
    Volavka, J
    Lieberman, JA
    Kennedy, JL
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 82 - 82
12345